{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:05:44Z","timestamp":1794639944535,"version":"4.9.1"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1038\/s41584-023-00932-6","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T21:27:02Z","timestamp":1678742822000},"page":"288-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":171,"title":["Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies"],"prefix":"10.1038","volume":"19","author":[{"given":"Gudny Ella","family":"Thorlacius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albin","family":"Bj\u00f6rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0915-7245","authenticated-orcid":false,"given":"Marie","family":"Wahren-Herlenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"932_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2014.931457","volume":"44","author":"M Kvarnstr\u00f6m","year":"2015","unstructured":"Kvarnstr\u00f6m, M., Ottosson, V., Nordmark, B. & Wahren-Herlenius, M. Incident cases of primary Sj\u00f6gren\u2019s syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics. Scand. J. Rheumatol. 44, 135\u2013142 (2015).","journal-title":"Scand. J. Rheumatol."},{"key":"932_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette, X. & Criswell, L. A. Primary Sj\u00f6gren\u2019s syndrome. N. Engl. J. Med. 378, 931\u2013939 (2018).","journal-title":"N. Engl. J. Med."},{"key":"932_CR3","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1093\/rheumatology\/kez578","volume":"59","author":"P Brito-Zer\u00f3n","year":"2020","unstructured":"Brito-Zer\u00f3n, P. et al. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sj\u00f6gren\u2019s syndrome. Rheumatology 59, 2350\u20132359 (2020).","journal-title":"Rheumatology"},{"key":"932_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski, C. H. et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann. Rheum. Dis. 76, 9\u201316 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/joim.12888","volume":"285","author":"J Mofors","year":"2019","unstructured":"Mofors, J. et al. Infections increase the risk of developing Sj\u00f6gren\u2019s syndrome. J. Intern. Med. 285, 670\u2013680 (2019).","journal-title":"J. Intern. Med."},{"key":"932_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/joim.12941","volume":"286","author":"J Mofors","year":"2019","unstructured":"Mofors, J. et al. Concomitant Ro\/SSA and La\/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sj\u00f6gren\u2019s syndrome. J. Intern. Med. 286, 458\u2013468 (2019).","journal-title":"J. Intern. Med."},{"key":"932_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/joim.12346","volume":"278","author":"E Bartoloni","year":"2015","unstructured":"Bartoloni, E. et al. Cardiovascular disease risk burden in primary Sj\u00f6gren\u2019s syndrome: results of a population-based multicentre cohort study. J. Intern. Med. 278, 185\u2013192 (2015).","journal-title":"J. Intern. Med."},{"key":"932_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/bjh.13192","volume":"168","author":"G Nocturne","year":"2015","unstructured":"Nocturne, G. & Mariette, X. Sj\u00f6gren syndrome-associated lymphomas: an update on pathogenesis and management. Br. J. Haematol. 168, 317\u2013327 (2015).","journal-title":"Br. J. Haematol."},{"key":"932_CR9","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/ard.2005.041186","volume":"65","author":"E Theander","year":"2006","unstructured":"Theander, E. et al. Lymphoma and other malignancies in primary Sj\u00f6gren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann. Rheum. Dis. 65, 796\u2013803 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.yexcr.2014.01.003","volume":"325","author":"A Ambrosi","year":"2014","unstructured":"Ambrosi, A., Sonesson, S. E. & Wahren-Herlenius, M. Molecular mechanisms of congenital heart block. Exp. Cell Res. 325, 2\u20139 (2014).","journal-title":"Exp. Cell Res."},{"key":"932_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals, M. et al. EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies. Ann. Rheum. Dis. 79, 3\u201318 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41584-021-00634-x","volume":"17","author":"R Seror","year":"2021","unstructured":"Seror, R., Nocturne, G. & Mariette, X. Current and future therapies for primary Sj\u00f6gren syndrome. Nat. Rev. Rheumatol. 17, 475\u2013486 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"932_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key360","author":"ILA Bodewes","year":"2019","unstructured":"Bodewes, I. L. A., Bj\u00f6rk, A., Versnel, M. A. & Wahren-Herlenius, M. Innate immunity and interferons in the pathogenesis of Sj\u00f6gren\u2019s syndrome. Rheumatology https:\/\/doi.org\/10.1093\/rheumatology\/key360 (2019).","journal-title":"Rheumatology"},{"key":"932_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","volume":"14","author":"G Nocturne","year":"2018","unstructured":"Nocturne, G. & Mariette, X. B cells in the pathogenesis of primary Sj\u00f6gren syndrome. Nat. Rev. Rheumatol. 14, 133\u2013145 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"932_CR15","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1002\/art.11311","volume":"48","author":"S Salomonsson","year":"2003","unstructured":"Salomonsson, S. et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 48, 3187\u20133201 (2003).","journal-title":"Arthritis Rheum."},{"key":"932_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","volume":"13","author":"M Bombardieri","year":"2017","unstructured":"Bombardieri, M., Lewis, M. & Pitzalis, C. Ectopic lymphoid neogenesis in rheumatic autoimmune diseases. Nat. Rev. Rheumatol. 13, 141\u2013154 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"932_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.semarthrit.2017.06.007","volume":"47","author":"CJ Ulff-M\u00f8ller","year":"2018","unstructured":"Ulff-M\u00f8ller, C. J., Svendsen, A. J., Viemose, L. N. & Jacobsen, S. Concordance of autoimmune disease in a nationwide Danish systemic lupus erythematosus twin cohort. Semin. Arthritis Rheum. 47, 538\u2013544 (2018).","journal-title":"Semin. Arthritis Rheum."},{"key":"932_CR18","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/rheumatology\/32.10.903","volume":"32","author":"AJ Silman","year":"1993","unstructured":"Silman, A. J. et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br. J. Rheumatol. 32, 903\u2013907 (1993).","journal-title":"Br. J. Rheumatol."},{"key":"932_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/joim.13032","volume":"287","author":"A Bj\u00f6rk","year":"2020","unstructured":"Bj\u00f6rk, A., Mofors, J. & Wahren-Herlenius, M. Environmental factors in the pathogenesis of primary Sj\u00f6gren\u2019s syndrome. J. Intern. Med. 287, 475\u2013492 (2020).","journal-title":"J. Intern. Med."},{"key":"932_CR20","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/art.39127","volume":"67","author":"CF Kuo","year":"2015","unstructured":"Kuo, C. F. et al. Familial risk of Sj\u00f6gren\u2019s syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study. Arthritis Rheumatol. 67, 1904\u20131912 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"932_CR21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/1756-185X.12398","volume":"17","author":"WS Lee","year":"2014","unstructured":"Lee, W. S. & Yoo, W. H. Primary Sj\u00f6gren\u2019s syndrome in monozygotic twins. Int. J. Rheum. Dis. 17, 578\u2013579 (2014).","journal-title":"Int. J. Rheum. Dis."},{"key":"932_CR22","first-page":"2264","volume":"27","author":"AI Bolstad","year":"2000","unstructured":"Bolstad, A. I., Haga, H. J., Wassmuth, R. & Jonsson, R. Monozygotic twins with primary Sj\u00f6gren\u2019s syndrome. J. Rheumatol. 27, 2264\u20132266 (2000).","journal-title":"J. Rheumatol."},{"key":"932_CR23","first-page":"1603","volume":"32","author":"KM Houghton","year":"2005","unstructured":"Houghton, K. M., Cabral, D. A., Petty, R. E. & Tucker, L. B. Primary Sj\u00f6gren\u2019s syndrome in dizygotic adolescent twins: one case with lymphocytic interstitial pneumonia. J. Rheumatol. 32, 1603\u20131606 (2005).","journal-title":"J. Rheumatol."},{"key":"932_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/096120339700600409","volume":"6","author":"RH Scofield","year":"1997","unstructured":"Scofield, R. H., Kurien, B. T. & Reichlin, M. Immunologically restricted and inhibitory anti-Ro\/SSA in monozygotic twins. Lupus 6, 395\u2013398 (1997).","journal-title":"Lupus"},{"key":"932_CR25","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/rheumatology\/key330","volume":"60","author":"J Imgenberg-Kreuz","year":"2021","unstructured":"Imgenberg-Kreuz, J., Rasmussen, A., Sivils, K. & Nordmark, G. Genetics and epigenetics in primary Sj\u00f6gren\u2019s syndrome. Rheumatology 60, 2085\u20132098 (2021).","journal-title":"Rheumatology"},{"key":"932_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaut.2012.01.008","volume":"39","author":"JA Ice","year":"2012","unstructured":"Ice, J. A. et al. Genetics of Sj\u00f6gren\u2019s syndrome in the genome-wide association era. J. Autoimmun. 39, 57\u201363 (2012).","journal-title":"J. Autoimmun."},{"key":"932_CR27","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/ng.2779","volume":"45","author":"Y Li","year":"2013","unstructured":"Li, Y. et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sj\u00f6gren\u2019s syndrome at 7q11.23. Nat. Genet. 45, 1361\u20131365 (2013).","journal-title":"Nat. Genet."},{"key":"932_CR28","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00439-016-1716-0","volume":"135","author":"IW Song","year":"2016","unstructured":"Song, I. W. et al. Identification of susceptibility gene associated with female primary Sj\u00f6gren\u2019s syndrome in Han Chinese by genome-wide association study. Hum. Genet. 135, 1287\u20131294 (2016).","journal-title":"Hum. Genet."},{"key":"932_CR29","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/art.40040","volume":"69","author":"KE Taylor","year":"2017","unstructured":"Taylor, K. E. et al. Genome-wide association analysis reveals genetic heterogeneity of Sj\u00f6gren\u2019s syndrome according to ancestry. Arthritis Rheumatol. 69, 1294\u20131305 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"932_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30773-y","volume":"13","author":"B Khatri","year":"2022","unstructured":"Khatri, B. et al. Genome-wide association study identifies Sj\u00f6gren\u2019s risk loci with functional implications in immune and glandular cells. Nat. Commun. 13, 4287 (2022).","journal-title":"Nat. Commun."},{"key":"932_CR31","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.2792","volume":"45","author":"CJ Lessard","year":"2013","unstructured":"Lessard, C. J. et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren\u2019s syndrome. Nat. Genet. 45, 1284\u20131292 (2013).","journal-title":"Nat. Genet."},{"key":"932_CR32","first-page":"837","volume":"60","author":"GE Thorlacius","year":"2021","unstructured":"Thorlacius, G. E. et al. Genetic and clinical basis for two distinct subtypes of primary Sj\u00f6gren\u2019s syndrome. Rheumatology 60, 837\u2013848 (2021).","journal-title":"Rheumatology"},{"key":"932_CR33","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1093\/hmg\/ddx135","volume":"26","author":"R Carapito","year":"2017","unstructured":"Carapito, R. et al. A new MHC-linked susceptibility locus for primary Sj\u00f6gren\u2019s syndrome: MICA. Hum. Mol. Genet. 26, 2565\u20132576 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"932_CR34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ng.3782","volume":"49","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat. Genet. 49, 433\u2013437 (2017).","journal-title":"Nat. Genet."},{"key":"932_CR35","doi-asserted-by":"publisher","first-page":"e1006820","DOI":"10.1371\/journal.pgen.1006820","volume":"13","author":"H Li","year":"2017","unstructured":"Li, H. et al. Identification of a Sj\u00f6gren\u2019s syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genet. 13, e1006820 (2017).","journal-title":"PLoS Genet."},{"key":"932_CR36","doi-asserted-by":"publisher","first-page":"e0177320","DOI":"10.1371\/journal.pone.0177320","volume":"12","author":"S Qu","year":"2017","unstructured":"Qu, S. et al. Common variants near IKZF1 are associated with primary Sj\u00f6gren\u2019s syndrome in Han Chinese. PLoS ONE 12, e0177320 (2017).","journal-title":"PLoS ONE"},{"key":"932_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/annrheumdis-2011-200446","volume":"71","author":"AI Bolstad","year":"2012","unstructured":"Bolstad, A. I. et al. Association between genetic variants in the tumour necrosis factor\/lymphotoxin \u03b1\/lymphotoxin \u03b2 locus and primary Sjogren\u2019s syndrome in Scandinavian samples. Ann. Rheum. Dis. 71, 981\u2013988 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/gene.2010.64","volume":"12","author":"SL Musone","year":"2011","unstructured":"Musone, S. L. et al. Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases. Genes Immun. 12, 176\u2013182 (2011).","journal-title":"Genes Immun."},{"key":"932_CR39","doi-asserted-by":"publisher","first-page":"e001832","DOI":"10.1136\/rmdopen-2021-001832","volume":"7","author":"KB Norheim","year":"2021","unstructured":"Norheim, K. B. et al. Genetic variants at the RTP4\/MASP1 locus are associated with fatigue in Scandinavian patients with primary Sj\u00f6gren\u2019s syndrome. RMD Open 7, e001832 (2021).","journal-title":"RMD Open"},{"key":"932_CR40","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","volume":"122","author":"G Nocturne","year":"2013","unstructured":"Nocturne, G. et al. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren\u2019s syndrome. Blood 122, 4068\u20134076 (2013).","journal-title":"Blood"},{"key":"932_CR41","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1136\/annrheumdis-2015-207731","volume":"75","author":"G Nocturne","year":"2016","unstructured":"Nocturne, G. et al. Germline variation of TNFAIP3 in primary Sj\u00f6gren\u2019s syndrome-associated lymphoma. Ann. Rheum. Dis. 75, 780\u2013783 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR42","doi-asserted-by":"publisher","first-page":"6923213","DOI":"10.1155\/2018\/6923213","volume":"2018","author":"A Nezos","year":"2018","unstructured":"Nezos, A. et al. TNFAIP3 F127C coding variation in Greek primary Sjogren\u2019s syndrome patients. J. Immunol. Res. 2018, 6923213 (2018).","journal-title":"J. Immunol. Res."},{"key":"932_CR43","doi-asserted-by":"publisher","first-page":"102317","DOI":"10.1016\/j.jaut.2019.102317","volume":"104","author":"A Nezos","year":"2019","unstructured":"Nezos, A., Evangelopoulos, M. E. & Mavragani, C. P. Genetic contributors and soluble mediators in prediction of autoimmune comorbidity. J. Autoimmun. 104, 102317 (2019).","journal-title":"J. Autoimmun."},{"key":"932_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.autrev.2018.08.007","volume":"18","author":"AV Goules","year":"2019","unstructured":"Goules, A. V. & Tzioufas, A. G. Lymphomagenesis in Sj\u00f6gren\u2019s syndrome: predictive biomarkers towards precision medicine. Autoimmun. Rev. 18, 137\u2013143 (2019).","journal-title":"Autoimmun. Rev."},{"key":"932_CR45","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.biochi.2012.05.016","volume":"94","author":"G Auclair","year":"2012","unstructured":"Auclair, G. & Weber, M. Mechanisms of DNA methylation and demethylation in mammals. Biochimie 94, 2202\u20132211 (2012).","journal-title":"Biochimie"},{"key":"932_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/gene.2009.20","volume":"10","author":"ES Emamian","year":"2009","unstructured":"Emamian, E. S. et al. Peripheral blood gene expression profiling in Sj\u00f6gren\u2019s syndrome. Genes Immun. 10, 285\u2013296 (2009).","journal-title":"Genes Immun."},{"key":"932_CR47","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1002\/eji.200738008","volume":"38","author":"ME Wildenberg","year":"2008","unstructured":"Wildenberg, M. E., van Helden-Meeuwsen, C. G., van de Merwe, J. P., Drexhage, H. A. & Versnel, M. A. Systemic increase in type I interferon activity in Sj\u00f6gren\u2019s syndrome: a putative role for plasmacytoid dendritic cells. Eur. J. Immunol. 38, 2024\u20132033 (2008).","journal-title":"Eur. J. Immunol."},{"key":"932_CR48","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1073\/pnas.0510837103","volume":"103","author":"JE Gottenberg","year":"2006","unstructured":"Gottenberg, J. E. et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sj\u00f6gren\u2019s syndrome. Proc. Natl Acad. Sci. USA 103, 2770\u20132775 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"932_CR49","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/art.21006","volume":"52","author":"TO Hjelmervik","year":"2005","unstructured":"Hjelmervik, T. O., Petersen, K., Jonassen, I., Jonsson, R. & Bolstad, A. I. Gene expression profiling of minor salivary glands clearly distinguishes primary Sj\u00f6gren\u2019s syndrome patients from healthy control subjects. Arthritis Rheum. 52, 1534\u20131544 (2005).","journal-title":"Arthritis Rheum."},{"key":"932_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clim.2016.01.011","volume":"164","author":"B Sun","year":"2016","unstructured":"Sun, B. et al. DNA methylation perspectives in the pathogenesis of autoimmune diseases. Clin. Immunol. 164, 21\u201327 (2016).","journal-title":"Clin. Immunol."},{"key":"932_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.clim.2018.04.004","volume":"196","author":"J Imgenberg-Kreuz","year":"2018","unstructured":"Imgenberg-Kreuz, J., Sandling, J. K. & Nordmark, G. Epigenetic alterations in primary Sj\u00f6gren\u2019s syndrome \u2013 an overview. Clin. Immunol. 196, 12\u201320 (2018).","journal-title":"Clin. Immunol."},{"key":"932_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01324-0","volume":"11","author":"M Teruel","year":"2021","unstructured":"Teruel, M. et al. Integrative epigenomics in Sj\u00f6gren\u00b4s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature. Sci. Rep. 11, 23292 (2021).","journal-title":"Sci. Rep."},{"key":"932_CR53","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1136\/annrheumdis-2015-208659","volume":"75","author":"J Imgenberg-Kreuz","year":"2016","unstructured":"Imgenberg-Kreuz, J. et al. Genome-wide DNA methylation analysis in multiple tissues in primary Sj\u00f6gren\u2019s syndrome reveals regulatory effects at interferon-induced genes. Ann. Rheum. Dis. 75, 2029\u20132036 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR54","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/art.38264","volume":"66","author":"N Altorok","year":"2014","unstructured":"Altorok, N. et al. Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 66, 731\u2013739 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"932_CR55","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/annrheumdis-2014-206998","volume":"75","author":"C Miceli-Richard","year":"2016","unstructured":"Miceli-Richard, C. et al. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 75, 933\u2013940 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR56","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1002\/art.39792","volume":"68","author":"MB Cole","year":"2016","unstructured":"Cole, M. B. et al. Epigenetic signatures of salivary gland inflammation in Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 68, 2936\u20132944 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"932_CR57","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/annrheumdis-2016-210167","volume":"76","author":"A Charras","year":"2017","unstructured":"Charras, A. et al. Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 76, 625\u2013628 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR58","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/rheumatology\/kew008","volume":"55","author":"K Br\u00e6kke Norheim","year":"2016","unstructured":"Br\u00e6kke Norheim, K. et al. Epigenome-wide DNA methylation patterns associated with fatigue in primary Sj\u00f6gren\u2019s syndrome. Rheumatology 55, 1074\u20131082 (2016).","journal-title":"Rheumatology"},{"key":"932_CR59","doi-asserted-by":"publisher","first-page":"e0248429","DOI":"10.1371\/journal.pone.0248429","volume":"16","author":"C Chi","year":"2021","unstructured":"Chi, C. et al. Hypomethylation mediates genetic association with the major histocompatibility complex genes in Sj\u00f6gren\u2019s syndrome. PLoS ONE 16, e0248429 (2021).","journal-title":"PLoS ONE"},{"key":"932_CR60","doi-asserted-by":"publisher","first-page":"e13145","DOI":"10.1111\/sji.13145","volume":"95","author":"R Jonsson","year":"2022","unstructured":"Jonsson, R. Disease mechanisms in Sj\u00f6gren\u2019s syndrome: what do we know? Scand. J. Immunol. 95, e13145 (2022).","journal-title":"Scand. J. Immunol."},{"key":"932_CR61","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/1744666X.2018.1519396","volume":"14","author":"ILA Bodewes","year":"2018","unstructured":"Bodewes, I. L. A. & Versnel, M. A. Interferon activation in primary Sj\u00f6gren\u2019s syndrome: recent insights and future perspective as novel treatment target. Expert Rev. Clin. Immunol. 14, 817\u2013829 (2018).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"932_CR62","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/annrheumdis-2012-201381","volume":"72","author":"Z Brkic","year":"2013","unstructured":"Brkic, Z. et al. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren\u2019s syndrome and association with disease activity and BAFF gene expression. Ann. Rheum. Dis. 72, 728\u2013735 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR63","doi-asserted-by":"publisher","first-page":"e000995","DOI":"10.1136\/rmdopen-2019-000995","volume":"6","author":"A Bj\u00f6rk","year":"2020","unstructured":"Bj\u00f6rk, A. et al. Protein and DNA methylation-based scores as surrogate markers for interferon system activation in patients with primary Sj\u00f6gren\u2019s syndrome. RMD Open 6, e000995 (2020).","journal-title":"RMD Open"},{"key":"932_CR64","doi-asserted-by":"publisher","first-page":"702037","DOI":"10.3389\/fimmu.2021.702037","volume":"12","author":"J Imgenberg-Kreuz","year":"2021","unstructured":"Imgenberg-Kreuz, J. et al. DNA methylation-based interferon scores associate with sub-phenotypes in primary Sj\u00f6gren\u2019s syndrome. Front. Immunol. 12, 702037 (2021).","journal-title":"Front. Immunol."},{"key":"932_CR65","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.clim.2014.06.001","volume":"153","author":"E Lazzari","year":"2014","unstructured":"Lazzari, E. & Jefferies, C. A. IRF5-mediated signaling and implications for SLE. Clin. Immunol. 153, 343\u2013352 (2014).","journal-title":"Clin. Immunol."},{"key":"932_CR66","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/gene.2008.94","volume":"10","author":"G Nordmark","year":"2009","unstructured":"Nordmark, G. et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sj\u00f6gren\u2019s syndrome. Genes. Immun. 10, 68\u201376 (2009).","journal-title":"Genes. Immun."},{"key":"932_CR67","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1093\/hmg\/ddy140","volume":"27","author":"ZH Patel","year":"2018","unstructured":"Patel, Z. H. et al. A plausibly causal functional lupus-associated risk variant in the STAT1\u2013STAT4 locus. Hum. Mol. Genet. 27, 2392\u20132404 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"932_CR68","doi-asserted-by":"publisher","first-page":"e12089","DOI":"10.7554\/eLife.12089","volume":"5","author":"P Raj","year":"2016","unstructured":"Raj, P. et al. Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity. Elife 5, e12089 (2016).","journal-title":"Elife"},{"key":"932_CR69","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/annrheumdis-2017-212794","volume":"77","author":"N Hagberg","year":"2018","unstructured":"Hagberg, N. et al. The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-\u03b3 production in T cells from patients with SLE. Ann. Rheum. Dis. 77, 1070\u20131077 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR70","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1517\/14728222.2014.892925","volume":"18","author":"Y Liang","year":"2014","unstructured":"Liang, Y. et al. Therapeutic potential of tyrosine kinase 2 in autoimmunity. Expert Opin. Ther. Targets 18, 571\u2013580 (2014).","journal-title":"Expert Opin. Ther. Targets"},{"key":"932_CR71","doi-asserted-by":"publisher","first-page":"e12894","DOI":"10.1111\/sji.12894","volume":"92","author":"N Hagberg","year":"2020","unstructured":"Hagberg, N., Lundtoft, C. & R\u00f6nnblom, L. Immunogenetics in systemic lupus erythematosus: transitioning from genetic associations to cellular effects. Scand. J. Immunol. 92, e12894 (2020).","journal-title":"Scand. J. Immunol."},{"key":"932_CR72","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1084\/jem.177.4.1199","volume":"177","author":"R Manetti","year":"1993","unstructured":"Manetti, R. et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199\u20131204 (1993).","journal-title":"J. Exp. Med."},{"key":"932_CR73","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","volume":"178","author":"A D\u2019Andrea","year":"1993","unstructured":"D\u2019Andrea, A. et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041\u20131048 (1993).","journal-title":"J. Exp. Med."},{"key":"932_CR74","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41588-021-00996-8","volume":"54","author":"JE Huffman","year":"2022","unstructured":"Huffman, J. E. et al. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19. Nat. Genet. 54, 125\u2013127 (2022).","journal-title":"Nat. Genet."},{"key":"932_CR75","doi-asserted-by":"publisher","first-page":"e1000321","DOI":"10.1371\/journal.ppat.1000321","volume":"5","author":"JK Lim","year":"2009","unstructured":"Lim, J. K. et al. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog. 5, e1000321 (2009).","journal-title":"PLoS Pathog."},{"key":"932_CR76","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10238-012-0193-6","volume":"13","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y., Kang, H., Ji, Y. & Chen, X. Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis. Clin. Exp. Med. 13, 171\u2013176 (2013).","journal-title":"Clin. Exp. Med."},{"key":"932_CR77","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/annrheumdis-2018-214127","volume":"78","author":"M Acosta-Herrera","year":"2019","unstructured":"Acosta-Herrera, M. et al. Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases. Ann. Rheum. Dis. 78, 311\u2013319 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR78","doi-asserted-by":"publisher","first-page":"6873","DOI":"10.1073\/pnas.92.15.6873","volume":"92","author":"MW Russo","year":"1995","unstructured":"Russo, M. W., Sevetson, B. R. & Milbrandt, J. Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc. Natl Acad. Sci. USA 92, 6873\u20136877 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"932_CR79","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.4049\/jimmunol.1203510","volume":"191","author":"SJ Kearney","year":"2013","unstructured":"Kearney, S. J. et al. Type I IFNs downregulate myeloid cell IFN-\u03b3 receptor by inducing recruitment of an early growth response 3\/NGFI-A binding protein 1 complex that silences Ifngr1 transcription. J. Immunol. 191, 3384\u20133392 (2013).","journal-title":"J. Immunol."},{"key":"932_CR80","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov, K. D., Boldin, M. P., Chang, K. J. & Baltimore, D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA 103, 12481\u201312486 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"932_CR81","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1084\/jem.20101823","volume":"208","author":"MP Boldin","year":"2011","unstructured":"Boldin, M. P. et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208, 1189\u20131201 (2011).","journal-title":"J. Exp. Med."},{"key":"932_CR82","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.imlet.2020.07.008","volume":"227","author":"SS Mortazavi-Jahromi","year":"2020","unstructured":"Mortazavi-Jahromi, S. S., Aslani, M. & Mirshafiey, A. A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases. Immunol. Lett. 227, 8\u201327 (2020).","journal-title":"Immunol. Lett."},{"key":"932_CR83","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/eji.201040757","volume":"41","author":"KM Pauley","year":"2011","unstructured":"Pauley, K. M. et al. Altered miR-146a expression in Sj\u00f6gren\u2019s syndrome and its functional role in innate immunity. Eur. J. Immunol. 41, 2029\u20132039 (2011).","journal-title":"Eur. J. Immunol."},{"key":"932_CR84","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.imlet.2011.09.006","volume":"141","author":"E Zilahi","year":"2012","unstructured":"Zilahi, E. et al. Increased microRNA-146a\/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sj\u00f6gren\u2019s syndrome. Immunol. Lett. 141, 165\u2013168 (2012).","journal-title":"Immunol. Lett."},{"key":"932_CR85","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/jop.12187","volume":"43","author":"H Shi","year":"2014","unstructured":"Shi, H., Zheng, L. Y., Zhang, P. & Yu, C. Q. miR-146a and miR-155 expression in PBMCs from patients with Sj\u00f6gren\u2019s syndrome. J. Oral. Pathol. Med. 43, 792\u2013797 (2014).","journal-title":"J. Oral. Pathol. Med."},{"key":"932_CR86","doi-asserted-by":"publisher","first-page":"e0174585","DOI":"10.1371\/journal.pone.0174585","volume":"12","author":"JQ Chen","year":"2017","unstructured":"Chen, J. Q. et al. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome. PLoS ONE 12, e0174585 (2017).","journal-title":"PLoS ONE"},{"key":"932_CR87","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/21655979.2020.1870321","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sj\u00f6gren\u2019s syndrome. Bioengineered 12, 310\u2013324 (2021).","journal-title":"Bioengineered"},{"key":"932_CR88","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/annrheumdis-2017-211417","volume":"77","author":"SF Wang-Renault","year":"2018","unstructured":"Wang-Renault, S. F. et al. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 77, 133\u2013140 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR89","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/cei.12703","volume":"183","author":"K Szab\u00f3","year":"2016","unstructured":"Szab\u00f3, K., Papp, G., Sz\u00e1nt\u00f3, A., Tarr, T. & Zeher, M. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus. Clin. Exp. Immunol. 183, 76\u201389 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"932_CR90","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V","volume":"41","author":"P Tengn\u00e9r","year":"1998","unstructured":"Tengn\u00e9r, P., Halse, A. K., Haga, H. J., Jonsson, R. & Wahren-Herlenius, M. Detection of anti-Ro\/SSA and anti-La\/SSB autoantibody-producing cells in salivary glands from patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 41, 2238\u20132248 (1998).","journal-title":"Arthritis Rheum."},{"key":"932_CR91","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/gene.2010.44","volume":"12","author":"G Nordmark","year":"2011","unstructured":"Nordmark, G. et al. Association of EBF1, FAM167A(C8orf13)\u2013BLK and TNFSF4 gene variants with primary Sj\u00f6gren\u2019s syndrome. Genes Immun. 12, 100\u2013109 (2011).","journal-title":"Genes Immun."},{"key":"932_CR92","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1136\/annrheumdis-2018-213634","volume":"77","author":"LA Aqrawi","year":"2018","unstructured":"Aqrawi, L. A. et al. Clinical associations and expression pattern of the autoimmunity susceptibility factor DIORA-1 in patients with primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 77, 1840\u20131842 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR93","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/cei.13138","volume":"193","author":"L Mentlein","year":"2018","unstructured":"Mentlein, L. et al. The rheumatic disease-associated FAM167A\u2013BLK locus encodes DIORA-1, a novel disordered protein expressed highly in bronchial epithelium and alveolar macrophages. Clin. Exp. Immunol. 193, 167\u2013177 (2018).","journal-title":"Clin. Exp. Immunol."},{"key":"932_CR94","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/cei.13118","volume":"192","author":"LA Aqrawi","year":"2018","unstructured":"Aqrawi, L. A. et al. Diminished CXCR5 expression in peripheral blood of patients with Sj\u00f6gren\u2019s syndrome may relate to both genotype and salivary gland homing. Clin. Exp. Immunol. 192, 259\u2013270 (2018).","journal-title":"Clin. Exp. Immunol."},{"key":"932_CR95","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0092-8674(00)81798-5","volume":"87","author":"R F\u00f6rster","year":"1996","unstructured":"F\u00f6rster, R. et al. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87, 1037\u20131047 (1996).","journal-title":"Cell"},{"key":"932_CR96","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/JLB.5MR1020-057RR","volume":"109","author":"W Chen","year":"2021","unstructured":"Chen, W., Yang, F., Xu, G., Ma, J. & Lin, J. Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sj\u00f6gren\u2019s syndrome. J. Leukoc. Biol. 109, 437\u2013447 (2021).","journal-title":"J. Leukoc. Biol."},{"key":"932_CR97","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/annrheumdis-2022-eular.2503","volume":"81","author":"MM Wiley","year":"2022","unstructured":"Wiley, M. M. et al. POS0096. Sj\u00f6gren\u2019s disease and systemic lupus erythematosus DDX6-CXCR5 risk intervals reveal common SNPs with functional significance in immune and salivary gland cells. Ann. Rheum. Dis. 81, 269\u2013270 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR98","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.celrep.2017.06.085","volume":"20","author":"JH Lumb","year":"2017","unstructured":"Lumb, J. H. et al. DDX6 represses aberrant activation of interferon-stimulated genes. Cell Rep. 20, 819\u2013831 (2017).","journal-title":"Cell Rep."},{"key":"932_CR99","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1073\/pnas.0911193107","volume":"107","author":"C Lien","year":"2010","unstructured":"Lien, C. et al. Critical role of IRF-5 in regulation of B-cell differentiation. Proc. Natl Acad. Sci. USA 107, 4664\u20134668 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"932_CR100","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gene.2012.10","volume":"13","author":"CM Fang","year":"2012","unstructured":"Fang, C. M. et al. Unique contribution of IRF-5\u2013Ikaros axis to the B-cell IgG2a response. Genes Immun. 13, 421\u2013430 (2012).","journal-title":"Genes Immun."},{"key":"932_CR101","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.autrev.2011.10.002","volume":"11","author":"P Cruz-Tapias","year":"2012","unstructured":"Cruz-Tapias, P., Rojas-Villarraga, A., Maier-Moore, S. & Anaya, J. M. HLA and Sj\u00f6gren\u2019s syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun. Rev. 11, 281\u2013287 (2012).","journal-title":"Autoimmun. Rev."},{"key":"932_CR102","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1002\/art.42265","volume":"74","author":"D Trutschel","year":"2022","unstructured":"Trutschel, D. et al. Variability in primary Sj\u00f6gren\u2019s syndrome is driven by interferon alpha, and genetically associated with the class II HLA DQ locus. Arthritis Rheumatol. 74, 1991\u20132002 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"932_CR103","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1080\/15548627.2019.1596493","volume":"15","author":"DS Oh","year":"2019","unstructured":"Oh, D. S. & Lee, H. K. Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells. Autophagy 15, 2091\u20132106 (2019).","journal-title":"Autophagy"},{"key":"932_CR104","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n, P. et al. Sj\u00f6gren syndrome. Nat. Rev. Dis. Prim. 2, 16047 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"932_CR105","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaut.2012.01.002","volume":"39","author":"AG Tzioufas","year":"2012","unstructured":"Tzioufas, A. G., Kapsogeorgou, E. K. & Moutsopoulos, H. M. Pathogenesis of Sj\u00f6gren\u2019s syndrome: what we know and what we should learn. J. Autoimmun. 39, 4\u20138 (2012).","journal-title":"J. Autoimmun."},{"key":"932_CR106","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.3389\/fimmu.2018.02334","volume":"9","author":"X Ye","year":"2018","unstructured":"Ye, X., Zhou, X. J. & Zhang, H. Exploring the role of autophagy-related gene 5 (ATG5) yields important insights into autophagy in autoimmune\/autoinflammatory diseases. Front. Immunol. 9, 2334 (2018).","journal-title":"Front. Immunol."},{"key":"932_CR107","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s13075-020-02317-6","volume":"22","author":"S Colafrancesco","year":"2020","unstructured":"Colafrancesco, S. et al. Autophagy occurs in lymphocytes infiltrating Sj\u00f6gren\u2019s syndrome minor salivary glands and correlates with histological severity of salivary gland lesions. Arthritis Res. Ther. 22, 238 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"932_CR108","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1017\/S1462399410001699","volume":"12","author":"VE Smith","year":"2010","unstructured":"Smith, V. E., Franklyn, J. A. & McCabe, C. J. Pituitary tumor-transforming gene and its binding factor in endocrine cancer. Expert Rev. Mol. Med. 12, e38 (2010).","journal-title":"Expert Rev. Mol. Med."},{"key":"932_CR109","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/cddiscovery.2016.24","volume":"2","author":"R Martin","year":"2016","unstructured":"Martin, R. et al. Caspase-mediated cleavage of raptor participates in the inactivation of mTORC1 during cell death. Cell Death Discov. 2, 16024 (2016).","journal-title":"Cell Death Discov."},{"key":"932_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1937-y","volume":"10","author":"D Priem","year":"2019","unstructured":"Priem, D. et al. A20 protects cells from TNF-induced apoptosis through linear ubiquitin-dependent and -independent mechanisms. Cell Death Dis. 10, 692 (2019).","journal-title":"Cell Death Dis."},{"key":"932_CR111","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13075-020-02281-1","volume":"22","author":"Y Wu","year":"2020","unstructured":"Wu, Y., He, X., Huang, N., Yu, J. & Shao, B. A20: a master regulator of arthritis. Arthritis Res. Ther. 22, 220 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"932_CR112","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jaut.2015.12.002","volume":"68","author":"OD Konsta","year":"2016","unstructured":"Konsta, O. D. et al. Defective DNA methylation in salivary gland epithelial acini from patients with Sj\u00f6gren\u2019s syndrome is associated with SSB gene expression, anti-SSB\/LA detection, and lymphocyte infiltration. J. Autoimmun. 68, 30\u201338 (2016).","journal-title":"J. Autoimmun."},{"key":"932_CR113","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jaut.2017.10.004","volume":"88","author":"CP Mavragani","year":"2018","unstructured":"Mavragani, C. P. et al. Defective regulation of L1 endogenous retroelements in primary Sjogren\u2019s syndrome and systemic lupus erythematosus: role of methylating enzymes. J. Autoimmun. 88, 75\u201382 (2018).","journal-title":"J. Autoimmun."},{"key":"932_CR114","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jaut.2018.02.007","volume":"90","author":"K Zhao","year":"2018","unstructured":"Zhao, K. et al. LINE1 contributes to autoimmunity through both RIG-I- and MDA5-mediated RNA sensing pathways. J. Autoimmun. 90, 105\u2013115 (2018).","journal-title":"J. Autoimmun."},{"key":"932_CR115","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/cei.13492","volume":"202","author":"P Karagianni","year":"2020","unstructured":"Karagianni, P., Goules, A. V. & Tzioufas, A. G. Epigenetic alterations in Sj\u00f6gren\u2019s syndrome patient saliva. Clin. Exp. Immunol. 202, 137\u2013143 (2020).","journal-title":"Clin. Exp. Immunol."},{"key":"932_CR116","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jaut.2016.05.013","volume":"74","author":"PR Nielsen","year":"2016","unstructured":"Nielsen, P. R., Kragstrup, T. W., Deleuran, B. W. & Benros, M. E. Infections as risk factor for autoimmune diseases \u2013 a nationwide study. J. Autoimmun. 74, 176\u2013181 (2016).","journal-title":"J. Autoimmun."},{"key":"932_CR117","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1600-0714.1995.tb01187.x","volume":"24","author":"N Maitland","year":"1995","unstructured":"Maitland, N., Flint, S., Scully, C. & Crean, S. J. Detection of cytomegalovirus and Epstein\u2013Barr virus in labial salivary glands in Sjogren\u2019s syndrome and non-specific sialadenitis. J. Oral. Pathol. Med. 24, 293\u2013298 (1995).","journal-title":"J. Oral. Pathol. Med."},{"key":"932_CR118","first-page":"1511","volume":"149","author":"S Wen","year":"1996","unstructured":"Wen, S. et al. Association of Epstein\u2013Barr virus (EBV) with Sj\u00f6gren\u2019s syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands. Am. J. Pathol. 149, 1511\u20131517 (1996).","journal-title":"Am. J. Pathol."},{"key":"932_CR119","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/art.38726","volume":"66","author":"C Croia","year":"2014","unstructured":"Croia, C. et al. Implication of Epstein\u2013Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 66, 2545\u20132557 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"932_CR120","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/joim.13058","volume":"287","author":"L Klareskog","year":"2020","unstructured":"Klareskog, L., R\u00f6nnelid, J., Saevarsdottir, S., Padyukov, L. & Alfredsson, L. The importance of differences; on environment and its interactions with genes and immunity in the causation of rheumatoid arthritis. J. Intern. Med. 287, 514\u2013533 (2020).","journal-title":"J. Intern. Med."},{"key":"932_CR121","doi-asserted-by":"publisher","first-page":"e001402","DOI":"10.1136\/rmdopen-2020-001402","volume":"6","author":"J Mofors","year":"2020","unstructured":"Mofors, J. et al. Cigarette smoking patterns preceding primary Sj\u00f6gren\u2019s syndrome. RMD Open 6, e001402 (2020).","journal-title":"RMD Open"},{"key":"932_CR122","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13075-017-1255-7","volume":"19","author":"P Olsson","year":"2017","unstructured":"Olsson, P., Turesson, C., Mandl, T., Jacobsson, L. & Theander, E. Cigarette smoking and the risk of primary Sj\u00f6gren\u2019s syndrome: a nested case control study. Arthritis Res. Ther. 19, 50 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"932_CR123","doi-asserted-by":"publisher","first-page":"e0170249","DOI":"10.1371\/journal.pone.0170249","volume":"12","author":"DU Stone","year":"2017","unstructured":"Stone, D. U. et al. Effect of tobacco smoking on the clinical, histopathological, and serological manifestations of Sj\u00f6gren\u2019s syndrome. PLoS ONE 12, e0170249 (2017).","journal-title":"PLoS ONE"},{"key":"932_CR124","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/acr2.11362","volume":"4","author":"EA Gebreegziabher","year":"2022","unstructured":"Gebreegziabher, E. A. et al. Associations between smoking and primary Sj\u00f6gren syndrome classification using the Sj\u00f6gren\u2019s international collaborative clinical alliance cohort. ACR Open Rheumatol. 4, 231\u2013237 (2022).","journal-title":"ACR Open Rheumatol."},{"key":"932_CR125","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/annrheumdis-2016-209952","volume":"76","author":"P Brito-Zer\u00f3n","year":"2017","unstructured":"Brito-Zer\u00f3n, P. et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sj\u00f6gren\u2019s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sj\u00f6gren Project Consortium. Ann. Rheum. Dis. 76, 1042\u20131050 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR126","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13293-015-0037-7","volume":"6","author":"JE Brandt","year":"2015","unstructured":"Brandt, J. E., Priori, R., Valesini, G. & Fairweather, D. Sex differences in Sj\u00f6gren\u2019s syndrome: a comprehensive review of immune mechanisms. Biol. Sex. Differ. 6, 19 (2015).","journal-title":"Biol. Sex. Differ."},{"key":"932_CR127","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16, 626\u2013638 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"932_CR128","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","volume":"20","author":"EP Scully","year":"2020","unstructured":"Scully, E. P., Haverfield, J., Ursin, R. L., Tannenbaum, C. & Klein, S. L. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat. Rev. Immunol. 20, 442\u2013447 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"932_CR129","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1126\/science.abe7199","volume":"371","author":"T Takahashi","year":"2021","unstructured":"Takahashi, T. & Iwasaki, A. Sex differences in immune responses. Science 371, 347\u2013348 (2021).","journal-title":"Science"},{"key":"932_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-33","volume":"15","author":"R Jansen","year":"2014","unstructured":"Jansen, R. et al. Sex differences in the human peripheral blood transcriptome. BMC Genomics 15, 33 (2014).","journal-title":"BMC Genomics"},{"key":"932_CR131","doi-asserted-by":"publisher","first-page":"107795","DOI":"10.1016\/j.celrep.2020.107795","volume":"31","author":"CM Lopes-Ramos","year":"2020","unstructured":"Lopes-Ramos, C. M. et al. Sex differences in gene expression and regulatory networks across 29 human tissues. Cell Rep. 31, 107795 (2020).","journal-title":"Cell Rep."},{"key":"932_CR132","doi-asserted-by":"publisher","first-page":"E488","DOI":"10.1073\/pnas.1714765115","volume":"115","author":"B Piasecka","year":"2018","unstructured":"Piasecka, B. et al. Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges. Proc. Natl Acad. Sci. USA 115, E488\u2013E497 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"932_CR133","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41576-018-0083-1","volume":"20","author":"EA Khramtsova","year":"2019","unstructured":"Khramtsova, E. A., Davis, L. K. & Stranger, B. E. The role of sex in the genomics of human complex traits. Nat. Rev. Genet. 20, 173\u2013190 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"932_CR134","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrrheum.2014.144","volume":"10","author":"GC Hughes","year":"2014","unstructured":"Hughes, G. C. & Choubey, D. Modulation of autoimmune rheumatic diseases by oestrogen and progesterone. Nat. Rev. Rheumatol. 10, 740\u2013751 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"932_CR135","first-page":"1267","volume":"30","author":"MT Brennan","year":"2003","unstructured":"Brennan, M. T. et al. Sex steroid hormones in primary Sj\u00f6gren\u2019s syndrome. J. Rheumatol. 30, 1267\u20131271 (2003).","journal-title":"J. Rheumatol."},{"key":"932_CR136","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/acr.24014","volume":"72","author":"SS McCoy","year":"2020","unstructured":"McCoy, S. S., Sampene, E. & Baer, A. N. Association of Sj\u00f6gren\u2019s syndrome with reduced lifetime sex hormone exposure: a case-control study. Arthritis Care Res. 72, 1315\u20131322 (2020).","journal-title":"Arthritis Care Res."},{"key":"932_CR137","first-page":"1259","volume":"28","author":"ST Valtysd\u00f3ttir","year":"2001","unstructured":"Valtysd\u00f3ttir, S. T., Wide, L. & H\u00e4llgren, R. Low serum dehydroepiandrosterone sulfate in women with primary Sj\u00f6gren\u2019s syndrome as an isolated sign of impaired HPA axis function. J. Rheumatol. 28, 1259\u20131265 (2001).","journal-title":"J. Rheumatol."},{"key":"932_CR138","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1210\/jc.2009-0106","volume":"94","author":"H Forsblad-d\u2019Elia","year":"2009","unstructured":"Forsblad-d\u2019Elia, H., Carlsten, H., Labrie, F., Konttinen, Y. T. & Ohlsson, C. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren\u2019s syndrome; supplementation with dehydroepiandrosterone restores the concentrations. J. Clin. Endocrinol. Metab. 94, 2044\u20132051 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"932_CR139","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cellimm.2015.01.018","volume":"294","author":"S Kovats","year":"2015","unstructured":"Kovats, S. Estrogen receptors regulate innate immune cells and signaling pathways. Cell Immunol. 294, 63\u201369 (2015).","journal-title":"Cell Immunol."},{"key":"932_CR140","doi-asserted-by":"publisher","first-page":"206","DOI":"10.55563\/clinexprheumatol\/88dyrn","volume":"39","author":"LG Chatzis","year":"2021","unstructured":"Chatzis, L. G., Goules, A. V. & Tzioufas, A. G. Searching for the \u201cX factor\u201d in Sj\u00f6gren\u2019s syndrome female predilection. Clin. Exp. Rheumatol. 39, 206\u2013214 (2021).","journal-title":"Clin. Exp. Rheumatol."},{"key":"932_CR141","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clim.2016.04.002","volume":"168","author":"VM Harris","year":"2016","unstructured":"Harris, V. M. et al. Klinefelter\u2019s syndrome (47,XXY) is in excess among men with Sj\u00f6gren\u2019s syndrome. Clin. Immunol. 168, 25\u201329 (2016).","journal-title":"Clin. Immunol."},{"key":"932_CR142","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.39560","volume":"68","author":"K Liu","year":"2016","unstructured":"Liu, K. et al. X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 68, 1290\u20131300 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"932_CR143","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/ijms22031114","volume":"22","author":"A Youness","year":"2021","unstructured":"Youness, A., Miquel, C. H. & Gu\u00e9ry, J. C. Escape from X chromosome inactivation and the female predominance in autoimmune diseases. Int. J. Mol. Sci. 22, 1114 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"932_CR144","doi-asserted-by":"publisher","first-page":"eaap8855","DOI":"10.1126\/sciimmunol.aap8855","volume":"3","author":"M Souyris","year":"2018","unstructured":"Souyris, M. et al. TLR7 escapes X chromosome inactivation in immune cells. Sci. Immunol. 3, eaap8855 (2018).","journal-title":"Sci. Immunol."},{"key":"932_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10106-2","volume":"10","author":"CA Odhams","year":"2019","unstructured":"Odhams, C. A. et al. Interferon inducible X-linked gene CXorf21 may contribute to sexual dimorphism in systemic lupus erythematosus. Nat. Commun. 10, 2164 (2019).","journal-title":"Nat. Commun."},{"key":"932_CR146","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457\u20131464 (2015).","journal-title":"Nat. Genet."},{"key":"932_CR147","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","volume":"605","author":"GJ Brown","year":"2022","unstructured":"Brown, G. J. et al. TLR7 gain-of-function genetic variation causes human lupus. Nature 605, 349\u2013356 (2022).","journal-title":"Nature"},{"key":"932_CR148","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41586-020-2282-0","volume":"581","author":"LX Heinz","year":"2020","unstructured":"Heinz, L. X. et al. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7\u20139. Nature 581, 316\u2013322 (2020).","journal-title":"Nature"},{"key":"932_CR149","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1093\/hmg\/dds304","volume":"21","author":"V Boraska","year":"2012","unstructured":"Boraska, V. et al. Genome-wide meta-analysis of common variant differences between men and women. Hum. Mol. Genet. 21, 4805\u20134815 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"932_CR150","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13293-017-0153-7","volume":"8","author":"M Lind\u00e9n","year":"2017","unstructured":"Lind\u00e9n, M. et al. Sex influences eQTL effects of SLE and Sj\u00f6gren\u2019s syndrome-associated genetic polymorphisms. Biol. Sex. Differ. 8, 34 (2017).","journal-title":"Biol. Sex. Differ."},{"key":"932_CR151","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nrg2415","volume":"9","author":"C Ober","year":"2008","unstructured":"Ober, C., Loisel, D. A. & Gilad, Y. Sex-specific genetic architecture of human disease. Nat. Rev. Genet. 9, 911\u2013922 (2008).","journal-title":"Nat. Rev. Genet."},{"key":"932_CR152","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1093\/hmg\/ddt582","volume":"23","author":"C Yao","year":"2014","unstructured":"Yao, C. et al. Sex- and age-interacting eQTLs in human complex diseases. Hum. Mol. Genet. 23, 1947\u20131956 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"932_CR153","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1101\/gr.197897.115","volume":"26","author":"KR Kukurba","year":"2016","unstructured":"Kukurba, K. R. et al. Impact of the X chromosome and sex on regulatory variation. Genome Res. 26, 768\u2013777 (2016).","journal-title":"Genome Res."},{"key":"932_CR154","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1101\/gr.134981.111","volume":"22","author":"AS Dimas","year":"2012","unstructured":"Dimas, A. S. et al. Sex-biased genetic effects on gene regulation in humans. Genome Res. 22, 2368\u20132375 (2012).","journal-title":"Genome Res."},{"key":"932_CR155","doi-asserted-by":"publisher","first-page":"eaba3066","DOI":"10.1126\/science.aba3066","volume":"369","author":"M Oliva","year":"2020","unstructured":"Oliva, M. et al. The impact of sex on gene expression across human tissues. Science 369, eaba3066 (2020).","journal-title":"Science"},{"key":"932_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80145-z","volume":"11","author":"MM Stein","year":"2021","unstructured":"Stein, M. M. et al. Sex-specific differences in peripheral blood leukocyte transcriptional response to LPS are enriched for HLA region and X chromosome genes. Sci. Rep. 11, 1107 (2021).","journal-title":"Sci. Rep."},{"key":"932_CR157","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41586-020-2277-x","volume":"582","author":"N Kamitaki","year":"2020","unstructured":"Kamitaki, N. et al. Complement genes contribute sex-biased vulnerability in diverse disorders. Nature 582, 577\u2013581 (2020).","journal-title":"Nature"},{"key":"932_CR158","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fgene.2014.00100","volume":"5","author":"A Ghorai","year":"2014","unstructured":"Ghorai, A. & Ghosh, U. miRNA gene counts in chromosomes vary widely in a species and biogenesis of miRNA largely depends on transcription or post-transcriptional processing of coding genes. Front. Genet. 5, 100 (2014).","journal-title":"Front. Genet."},{"key":"932_CR159","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13072-015-0035-3","volume":"8","author":"P Singmann","year":"2015","unstructured":"Singmann, P. et al. Characterization of whole-genome autosomal differences of DNA methylation between men and women. Epigenetics Chromatin 8, 43 (2015).","journal-title":"Epigenetics Chromatin"},{"key":"932_CR160","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cellimm.2015.01.004","volume":"294","author":"D Khan","year":"2015","unstructured":"Khan, D., Dai, R. & Ansar Ahmed, S. Sex differences and estrogen regulation of miRNAs in lupus, a prototypical autoimmune disease. Cell Immunol. 294, 70\u201379 (2015).","journal-title":"Cell Immunol."},{"key":"932_CR161","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fgene.2019.00313","volume":"10","author":"JJ Shen","year":"2019","unstructured":"Shen, J. J., Wang, Y. F. & Yang, W. Sex-interacting mRNA- and miRNA-eQTLs and their implications in gene expression regulation and disease. Front. Genet. 10, 313 (2019).","journal-title":"Front. Genet."},{"key":"932_CR162","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/art.20146","volume":"50","author":"X Mariette","year":"2004","unstructured":"Mariette, X. et al. Inefficacy of infliximab in primary Sj\u00f6gren\u2019s syndrome: results of the randomized, controlled Trial of Remicade in Primary Sj\u00f6gren\u2019s Syndrome (TRIPSS). Arthritis Rheum. 50, 1270\u20131276 (2004).","journal-title":"Arthritis Rheum."},{"key":"932_CR163","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/art.40093","volume":"69","author":"SJ Bowman","year":"2017","unstructured":"Bowman, S. J. et al. Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 69, 1440\u20131450 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"932_CR164","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7326\/M13-1085","volume":"160","author":"V Devauchelle-Pensec","year":"2014","unstructured":"Devauchelle-Pensec, V. et al. Treatment of primary Sj\u00f6gren syndrome with rituximab: a randomized trial. Ann. Intern. Med. 160, 233\u2013242 (2014).","journal-title":"Ann. Intern. Med."},{"key":"932_CR165","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/annrheumdis-2020-218599","volume":"80","author":"AN Baer","year":"2020","unstructured":"Baer, A. N. et al. Efficacy and safety of abatacept in active primary Sj\u00f6gren\u2019s syndrome: results of a phase III, randomised, placebo-controlled trial. Ann. Rheum. Dis. 80, 339\u2013348 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR166","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2020-218467","volume":"80","author":"R Felten","year":"2021","unstructured":"Felten, R. et al. Interleukin 6 receptor inhibition in primary Sj\u00f6gren syndrome: a multicentre double-blind randomised placebo-controlled trial. Ann. Rheum. Dis. 80, 329\u2013338 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR167","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0140-6736(21)02251-0","volume":"399","author":"SJ Bowman","year":"2022","unstructured":"Bowman, S. J. et al. Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sj\u00f6gren\u2019s syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial. Lancet 399, 161\u2013171 (2022).","journal-title":"Lancet"},{"key":"932_CR168","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/annrheumdis-2021-222054","volume":"81","author":"R Seror","year":"2022","unstructured":"Seror, R. et al. Development and preliminary validation of the Sj\u00f6gren\u2019s tool for assessing response (STAR): a consensual composite score for assessing treatment effect in primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 81, 979\u2013989 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR169","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1016\/S2665-9913(21)00122-3","volume":"3","author":"S Arends","year":"2021","unstructured":"Arends, S. et al. Composite of relevant endpoints for Sj\u00f6gren\u2019s syndrome (CRESS): development and validation of a novel outcome measure. Lancet Rheumatol. 3, e553\u2013e562 (2021).","journal-title":"Lancet Rheumatol."},{"key":"932_CR170","unstructured":"US National Library of Medicine. ClinicalTrials.gov, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04496960 (2023)."},{"key":"932_CR171","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/rheumatology\/keaa670","volume":"60","author":"MJ Barrera","year":"2021","unstructured":"Barrera, M. J. et al. Tofacitinib counteracts IL-6 overexpression induced by deficient autophagy: implications in Sj\u00f6gren\u2019s syndrome. Rheumatology 60, 1951\u20131962 (2021).","journal-title":"Rheumatology"},{"key":"932_CR172","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1136\/annrheumdis-2021-222053","volume":"81","author":"W Bai","year":"2022","unstructured":"Bai, W. et al. Pilot study of baricitinib for active Sjogren\u2019s syndrome. Ann. Rheum. Dis. 81, 1050\u20131052 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR173","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2217\/imt-2021-0096","volume":"13","author":"M Gonciarz","year":"2021","unstructured":"Gonciarz, M., Pawlak-Bu\u015b, K., Leszczy\u0144ski, P. & Owczarek, W. TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseases. Immunotherapy 13, 1135\u20131150 (2021).","journal-title":"Immunotherapy"},{"key":"932_CR174","unstructured":"US National Library of Medicine. ClinicalTrials.gov, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05617677 (2023)."},{"key":"932_CR175","unstructured":"US National Library of Medicine. ClinicalTrials.gov, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04093531 (2022)."},{"key":"932_CR176","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/JCI124466","volume":"129","author":"R Furie","year":"2019","unstructured":"Furie, R. et al. Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus. J. Clin. Invest. 129, 1359\u20131371 (2019).","journal-title":"J. Clin. Invest."},{"key":"932_CR177","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1912196","volume":"382","author":"EF Morand","year":"2020","unstructured":"Morand, E. F. et al. Trial of anifrolumab in active systemic lupus erythematosus. N. Engl. J. Med. 382, 211\u2013221 (2020).","journal-title":"N. Engl. J. Med."},{"key":"932_CR178","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s40265-021-01604-z","volume":"81","author":"ED Deeks","year":"2021","unstructured":"Deeks, E. D. Anifrolumab: first approval. Drugs 81, 1795\u20131802 (2021).","journal-title":"Drugs"},{"key":"932_CR179","unstructured":"US National Library of Medicine. ClinicalTrials.gov, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05383677 (2022)."},{"key":"932_CR180","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","volume":"80","author":"A Fanouriakis","year":"2021","unstructured":"Fanouriakis, A., Tziolos, N., Bertsias, G. & Boumpas, D. T. Update \u03bfn the diagnosis and management of systemic lupus erythematosus. Ann. Rheum. Dis. 80, 14\u201325 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR181","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","volume":"74","author":"X Mariette","year":"2015","unstructured":"Mariette, X. et al. Efficacy and safety of belimumab in primary Sj\u00f6gren\u2019s syndrome: results of the BELISS open-label phase II study. Ann. Rheum. Dis. 74, 526\u2013531 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"932_CR182","doi-asserted-by":"publisher","first-page":"e163030","DOI":"10.1172\/jci.insight.163030","volume":"7","author":"X Mariette","year":"2022","unstructured":"Mariette, X. et al. A randomized, phase II study of sequential belimumab and rituximab in primary Sj\u00f6gren\u2019s syndrome. JCI Insight 7, e163030 (2022).","journal-title":"JCI Insight"},{"issue":"Suppl. 9","key":"932_CR183","first-page":"Abstr. 2031","volume":"74","author":"D Xu","year":"2022","unstructured":"Xu, D. et al. Efficacy and safety of telitacicept in primary Sj\u00f6gren\u2019s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial. Arthritis Rheumatol. 74 (Suppl. 9), Abstr. 2031 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"932_CR184","unstructured":"US National Library of Medicine. ClinicalTrials.gov, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05673993 (2023)."},{"key":"932_CR185","doi-asserted-by":"publisher","first-page":"E153","DOI":"10.1016\/S2665-9913(19)30160-2","volume":"2","author":"JF van Nimwegen","year":"2020","unstructured":"van Nimwegen, J. F. et al. Abatacept treatment for patients with early active primary Sjogren\u2019s syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study). Lancet Rheumatol. 2, E153\u2013E163 (2020).","journal-title":"Lancet Rheumatol."},{"key":"932_CR186","doi-asserted-by":"publisher","first-page":"E142","DOI":"10.1016\/S2665-9913(19)30135-3","volume":"2","author":"BA Fisher","year":"2020","unstructured":"Fisher, B. A. et al. Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjogren\u2019s syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study. Lancet Rheumatol. 2, E142\u2013E152 (2020).","journal-title":"Lancet Rheumatol."},{"key":"932_CR187","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1080\/14656566.2021.1951224","volume":"22","author":"S Retamozo","year":"2021","unstructured":"Retamozo, S., Sis\u00f3-Almirall, A., Flores-Ch\u00e1vez, A., Ramos-Casals, M. & Brito-Zer\u00f3n, P. An update of targeted therapeutic options for primary Sj\u00f6gren syndrome: current status and future development. Expert Opin. Pharmacother. 22, 2359\u20132371 (2021).","journal-title":"Expert Opin. Pharmacother."},{"issue":"Suppl. 10","key":"932_CR188","first-page":"Abstr. 2417","volume":"71","author":"BM Mariette X","year":"2019","unstructured":"Mariette X, B. M. et al. A phase 2a study of MEDI5872 (AMG557), a fully human anti-ICOS ligand monoclonal antibody in patients with primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 71 (Suppl. 10), Abstr. 2417 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"932_CR189","doi-asserted-by":"publisher","first-page":"e12662","DOI":"10.1111\/sji.12662","volume":"87","author":"J Imgenberg-Kreuz","year":"2018","unstructured":"Imgenberg-Kreuz, J. et al. Transcription profiling of peripheral B cells in antibody-positive primary Sj\u00f6gren\u2019s syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature. Scand. J. Immunol. 87, e12662 (2018).","journal-title":"Scand. J. Immunol."},{"key":"932_CR190","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrc3702","volume":"14","author":"RW Hendriks","year":"2014","unstructured":"Hendriks, R. W., Yuvaraj, S. & Kil, L. P. Targeting Bruton\u2019s tyrosine kinase in B cell malignancies. Nat. Rev. Cancer 14, 219\u2013232 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"932_CR191","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-020-00963-z","volume":"20","author":"DD Griffin","year":"2020","unstructured":"Griffin, D. D. & Dolen, W. K. B cell disorders in children: part II. Curr. Allergy Asthma Rep. 20, 64 (2020).","journal-title":"Curr. Allergy Asthma Rep."},{"key":"932_CR192","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1182\/blood-2011-12-397919","volume":"119","author":"LP Kil","year":"2012","unstructured":"Kil, L. P. et al. Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. Blood 119, 3744\u20133756 (2012).","journal-title":"Blood"},{"issue":"Suppl. 9","key":"932_CR193","first-page":"Abstr. 1113","volume":"74","author":"T D\u00f6rner","year":"2022","unstructured":"D\u00f6rner, T. et al. Remibrutinib (LOU064) in Sj\u00f6gren\u2019s syndrome: safety and efficacy results from a 24-week placebo-controlled proof-of-concept study. Arthritis Rheumatol. 74 (Suppl. 9), Abstr. 1113 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"932_CR194","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1093\/rheumatology\/keac167","volume":"61","author":"E Price","year":"2022","unstructured":"Price, E. et al. Safety and efficacy of filgotinib, lanraplenib, and tirabrutinib in Sj\u00f6gren\u2019s syndrome: randomised, phase 2, double-blind, placebo-controlled study. Rheumatology 61, 4797\u20134808 (2022).","journal-title":"Rheumatology"},{"key":"932_CR195","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrrheum.2017.107","volume":"13","author":"J Pozsgay","year":"2017","unstructured":"Pozsgay, J., Szekanecz, Z. & S\u00e1rmay, G. Antigen-specific immunotherapies in rheumatic diseases. Nat. Rev. Rheumatol. 13, 525\u2013537 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"932_CR196","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nature16962","volume":"530","author":"X Clemente-Casares","year":"2016","unstructured":"Clemente-Casares, X. et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530, 434\u2013440 (2016).","journal-title":"Nature"},{"key":"932_CR197","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0167-5699(99)01458-9","volume":"20","author":"M Wahren-Herlenius","year":"1999","unstructured":"Wahren-Herlenius, M., Muller, S. & Isenberg, D. Analysis of B-cell epitopes of the Ro\/SS-A autoantigen. Immunol. Today 20, 234\u2013240 (1999).","journal-title":"Immunol. Today"},{"key":"932_CR198","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","volume":"17","author":"GM Verstappen","year":"2021","unstructured":"Verstappen, G. M., Pringle, S., Bootsma, H. & Kroese, F. G. M. Epithelial-immune cell interplay in primary Sj\u00f6gren syndrome salivary gland pathogenesis. Nat. Rev. Rheumatol. 17, 333\u2013348 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"932_CR199","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/19420862.2019.1624463","volume":"11","author":"RJ Benschop","year":"2019","unstructured":"Benschop, R. J. et al. Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. MAbs 11, 1175\u20131190 (2019).","journal-title":"MAbs"},{"key":"932_CR200","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41568-019-0109-9","volume":"19","author":"PA Jones","year":"2019","unstructured":"Jones, P. A., Ohtani, H., Chakravarthy, A. & De Carvalho, D. D. Epigenetic therapy in immune-oncology. Nat. Rev. Cancer 19, 151\u2013161 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"932_CR201","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.4049\/jimmunol.140.7.2197","volume":"140","author":"E Cornacchia","year":"1988","unstructured":"Cornacchia, E. et al. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J. Immunol. 140, 2197\u20132200 (1988).","journal-title":"J. Immunol."},{"key":"932_CR202","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/BOR.0000000000000522","volume":"30","author":"Y He","year":"2018","unstructured":"He, Y. & Sawalha, A. H. Drug-induced lupus erythematosus: an update on drugs and mechanisms. Curr. Opin. Rheumatol. 30, 490\u2013497 (2018).","journal-title":"Curr. Opin. Rheumatol."},{"key":"932_CR203","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","volume":"22","author":"D Wiener","year":"2021","unstructured":"Wiener, D. & Schwartz, S. The epitranscriptome beyond m(6)A. Nat. Rev. Genet. 22, 119\u2013131 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"932_CR204","doi-asserted-by":"publisher","first-page":"D1040","DOI":"10.1093\/nar\/gks1215","volume":"41","author":"I Rusinova","year":"2013","unstructured":"Rusinova, I. et al. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 41, D1040\u2013D1046 (2013).","journal-title":"Nucleic Acids Res."},{"key":"932_CR205","doi-asserted-by":"publisher","first-page":"D977","DOI":"10.1093\/nar\/gkac1010","volume":"51","author":"E Sollis","year":"2023","unstructured":"Sollis, E. et al. The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res. 51, D977\u2013D985 (2023).","journal-title":"Nucleic Acids Res."},{"key":"932_CR206","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","volume":"31","author":"MJ Machiela","year":"2015","unstructured":"Machiela, M. J. & Chanock, S. J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31, 3555\u20132557 (2015).","journal-title":"Bioinformatics"},{"key":"932_CR207","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996\u20131006 (2002).","journal-title":"Genome Res."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-00932-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-00932-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-00932-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:47:23Z","timestamp":1733957243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-00932-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":207,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["932"],"URL":"https:\/\/doi.org\/10.1038\/s41584-023-00932-6","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"13 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.W.-H. has received research grants from Merck KGaA and Janssen Pharmaceutica NV during the past 5 years. G.E.T. and A.B. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}